Posted on May 18, 2015
Imagine a day when you go in for a colonoscopy and a machine, not a person, sedates you. You may be familiar with this reality if you’ve come across Sedasys—an FDA-approved anesthesiology machine developed by Johnson & Johnson.
Posted on May 12, 2015
You may have heard that the U.S. Department of Health and Human Services (HHS) just clarified the Affordable Care Act’s policy on preventative care coverage regarding anesthesia services. The HHS made it clear that insurance companies can’t make you pay for anesthesia services related to preventive colonoscopies if the attending provider determines that anesthesia would be medically appropriate for the patient.
Posted on May 1, 2015
Eli Lilly and Company recently announced that the FDA has approved the use of Cyramza with FOLFIRI as a second-line treatment for colorectal cancer. This treatment, previously approved for use with advanced or metastatic gastric and lung cancer, now provides metastatic colorectal cancer patients with another biologic to use in the fight against their disease.
Posted on April 30, 2015
For the past year, members of the House Energy and Commerce Committee have asked patients, doctors, researchers and regulators:
- What needs to be done to develop new treatments and cures?
- How can we get these new therapies to patients faster? Read more
Posted on April 22, 2015
Scientific research is crucial to better understand the causes and factors associated with colon cancer. That’s why we established the Blue Hope Research Award, a one-year fellowship providing vital resources and funding to a bright investigator interested in making his or her mark in the colon cancer space.
Last year, we used the American Association for Cancer Research’s (AACR) peer-review process to fund critical research on biomarkers. We’re excited to announce that last night we officially presented our second annual Blue Hope Research award to Kent W. Mouw, M.D., Ph.D from the Dana-Farber Cancer Institute at the AACR’s Annual Meeting in Philadelphia, PA. Read more